A. Sbarai

Endothelial Cell-Associated Tissue Factor Pathway Inhibitor (TFPI) Antigen in Severe Nondiabetic Obese Patients: Effect of Hyperinsulinemia

M. Mussap, M. Plebani, R. Vettor, 1997, Seminars in thrombosis and hemostasis.

Tissue factor pathway inhibitor levels in patients with homocystinuria.

A. Girolami, W. Strauss, A. Burlina, 2000, Thrombosis research.

Tissue Factor Pathway Inhibitor Release Induced by Defibrotide and Heparins

D. Hoppensteadt, J. Fareed, G. Andreozzi, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Tissue Factor Pathway Inhibitor (TFPI) Antigen Plasma Level in Patients with Interstitial Lung Disease Before and After Heparin Administration

A. Cipriani, A. Tommasini, G. Cella, 1997, Seminars in thrombosis and hemostasis.

Plasma Markers of Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease

D. Hoppensteadt, J. Fareed, G. Cella, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Plasma markers of endothelial dysfunction in pulmonary hypertension.

F. Bellotto, F. Tona, J. Fareed, 2001, Chest.

Markers of endothelial function in pediatric stem cell transplantation for acute leukemia.

C. Messina, L. Zanesco, G. Cella, 2003, Medical and pediatric oncology.

Tissue factor pathway inhibitor (TFPI) activity in uremic patients during hemodialysis.

A. Naso, W. Strauss, G. Cella, 1996, Thrombosis research.

Soluble Plasma Thrombomodulin Levels in Patients with Chronic Myeloproliferative Disorder

A. Girolami, G. Cella, M. Randi, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Exogenous heparin reduces soluble plasma thrombomodulin levels.

A. Girolami, G. Cella, E. Rampin, 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.